Relevance of CPPC prospective nomination of desired T-cell states to "Select therapeutic targets for validation"
- Use case
- Select therapeutic targets for validation
- Assessed by
- CPPC prospective nomination of desired T-cell states
- Relevance
- Proxy evidence
- Endpoint
- Prospective nomination campaign: count of named targets improving the defined T-cell state objective.
Desired T-cell state changes provide experimentally measured target nomination evidence, but target efficacy/selectivity/rescue remain outside the measured endpoint.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
30 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations2 values
| Cancer Immunotherapy Data Science Challenge official code ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Citation locations2 values
| Cancer Immunotherapy Data Science Challenge ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.64898/2026.05.21.726863v1; 2026 preprint | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Cancer Immunotherapy Data Science Challenge official code ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Cancer Immunotherapy Data Science Challenge ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.64898/2026.05.21.726863v1; 2026 preprint | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Prospective nomination campaign: count of named targets improving the defined T-cell state objective. Context-only references | Cancer Immunotherapy Data Science Challenge official code ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Prospective nomination campaign: count of named targets improving the defined T-cell state objective. Context-only references | Cancer Immunotherapy Data Science Challenge ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.64898/2026.05.21.726863v1; 2026 preprint | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:ucc-research-protocol-cppc-prospective-selection Context-only references | Cancer Immunotherapy Data Science Challenge official code ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:ucc-research-protocol-cppc-prospective-selection Context-only references | Cancer Immunotherapy Data Science Challenge ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.64898/2026.05.21.726863v1; 2026 preprint | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations4 values
| Cancer Immunotherapy Data Science Challenge official code ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations4 values
| Cancer Immunotherapy Data Science Challenge ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.64898/2026.05.21.726863v1; 2026 preprint | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
2 source records and release history
- Cancer Immunotherapy Data Science Challenge · Original source · 10.64898/2026.05.21.726863v1; 2026 preprint
- Cancer Immunotherapy Data Science Challenge official code · Original source · 283328a9b8afc6e882eeb503ac4710bbe9f37371
Technical metadata and extraction receipts
Stable ID: use-case-mapping-20260930-346-910458dfd409
- field
- links:assessed_by:ucc-research-protocol-cppc-prospective-selection
- value
- ucc-research-protocol-cppc-prospective-selection
- relevance
- proxy
- endpoint
- Prospective nomination campaign: count of named targets improving the defined T-cell state objective.
- rationale
- Desired T-cell state changes provide experimentally measured target nomination evidence, but target efficacy/selectivity/rescue remain outside the measured endpoint.
- constraints
- Pooled nominations; not individual-method scores.; Mouse B16-OVA melanoma OT1 CD8 T-cell context.
- limitations
- No matched-budget conventional/random prospective comparison; no antitumor efficacy, rescue or selectivity result in this endpoint.; 61 nominations / Results 57 selected targets / README 59 targets / 50 post-QC perturbations need reconciliation; no success fraction calculated.; Preprint v1; original and reimplemented ranking scores kept separate. Screen2 ranking population is enriched by original nomination methods.; Automated source review only; independent human scientific review remains outstanding.
- revision
- 1
- reason
- Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations.
- citation locators
- source id: ucc-research-source-challenge-paper; locator: Abstract; Challenge 2; Figure 5; README; source id: ucc-research-source-challenge-code; locator: Abstract; Challenge 2; Figure 5; README
- source locator
- ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README
- review
- method: automated-source-review; reviewer: codex; reviewer note: Codex source curation, independent worker cross-review and root integration review; reviewed at: 2026-09-30T21:54:30.217Z; note: Source-backed literature curation with independent automated transcription and scope checks. No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
- reviewed evaluations
- ucc-research-eval-cppc-nominated-target-outcome
- pins
- record id: ucc-research-eval-cppc-nominated-target-outcome; fields: status; links; attributes.origin; attributes.comparison; sha256: 684176c1e8fe05a81b47abb7f69f8f1c6045fb264f9e165ba129f79adbfa61e9; record id: ucc-research-protocol-cppc-prospective-selection; fields: status; name; description; facets; source_ids; links; attributes; sha256: 39c63e680c2e163f90d984848f1ba4a9f1632834dda4eae29186ba63cad2254b; record id: ucc-research-result-cppc-nominated-target-outcome-named-desired-state-hits; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d743d517cdbace4d38c744688bbe023861c5f3a591ad92f5cb53369a820c0973; record id: ucc-research-source-challenge-code; fields: status; attributes.artifact_sha256; sha256: 8563974ad6eb67f251eccd6b608191b264bf7d35bf5024ed962982a8a3436f42; record id: ucc-research-source-challenge-paper; fields: status; attributes.artifact_sha256; sha256: 1b8bf53318d9c0b8488693b53f1981298c71d41c1dcf3667798bf75ffba54b29; record id: use-case-therapeutic-target-validation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 3b7601f2decfe5a3304ea2c8ccaa89929148f2d443b05bd6c9e92f1844c0a578